287 related articles for article (PubMed ID: 19549585)
41. Prevalence of drug resistance-related polymorphisms in treatment-naive individuals infected with nonsubtype B HIV type 1 in Cameroon.
Youngpairoj AS; Alemnji GA; Eno LT; Lyonga EJ; Eloundou MA; Shanmugam V; Mpoudi EN; Folks TM; Kalish ML; Pieniazek D; Fonjungo PN
AIDS Res Hum Retroviruses; 2012 Jul; 28(7):675-84. PubMed ID: 21923557
[TBL] [Abstract][Full Text] [Related]
42. Polymorphisms and resistance mutations in the protease and reverse transcriptase genes of HIV-1 F subtype Romanian strains.
Paraschiv S; Otelea D; Dinu M; Maxim D; Tinischi M
Int J Infect Dis; 2007 Mar; 11(2):123-8. PubMed ID: 16762582
[TBL] [Abstract][Full Text] [Related]
43. The role of polymorphisms at position 89 in the HIV-1 protease gene in the development of drug resistance to HIV-1 protease inhibitors.
Martinez-Cajas JL; Wainberg MA; Oliveira M; Asahchop EL; Doualla-Bell F; Lisovsky I; Moisi D; Mendelson E; Grossman Z; Brenner BG
J Antimicrob Chemother; 2012 Apr; 67(4):988-94. PubMed ID: 22315096
[TBL] [Abstract][Full Text] [Related]
44. Identification of alternative amino acid substitutions in drug-resistant variants of the HIV-1 reverse transcriptase.
Berkhout B; Back NK; de Ronde A; Jurriaans S; Bakker M; Parkin NT; van der Hoek L
AIDS; 2006 Jul; 20(11):1515-20. PubMed ID: 16847406
[TBL] [Abstract][Full Text] [Related]
45. Drug resistance-associated genotypic alterations in the pol gene of HIV type 1 isolates in ART-naive individuals in North India.
Arora SK; Gupta S; Toor JS; Singla A
AIDS Res Hum Retroviruses; 2008 Feb; 24(2):125-30. PubMed ID: 18240959
[TBL] [Abstract][Full Text] [Related]
46. Co-receptor usage and HIV-1 intra-clade C polymorphisms in the protease and reverse transcriptase genes of HIV-1 isolates from Ethiopia and Botswana.
Loemba H; Brenner B; Parniak MA; Ma'ayan S; Spira B; Moisi D; Oliveira M; Detorio M; Essex M; Wainberg MA
Antivir Ther; 2002 Jun; 7(2):141-8. PubMed ID: 12212926
[TBL] [Abstract][Full Text] [Related]
47. A sensitive genotyping assay for detection of drug resistance mutations in reverse transcriptase of HIV-1 subtypes B and C in samples stored as dried blood spots or frozen RNA extracts.
Ziemniak C; George-Agwu A; Moss WJ; Ray SC; Persaud D
J Virol Methods; 2006 Sep; 136(1-2):238-47. PubMed ID: 16828172
[TBL] [Abstract][Full Text] [Related]
48. Substitutions in the reverse transcriptase and protease genes of HIV-1 subtype B in untreated individuals and patients treated with antiretroviral drugs.
Turner D; Brenner B; Mosis D; Liang C; Wainberg MA
MedGenMed; 2005 Mar; 7(1):69. PubMed ID: 16369374
[TBL] [Abstract][Full Text] [Related]
49. Characteristics of HIV-1 non-B subtype infections in Northwest Poland.
Parczewski M; Leszczyszyn-Pynka M; Bander D; Urbańska A; Stańczak G; Boroń-Kaczmarska A
J Med Virol; 2010 Aug; 82(8):1306-13. PubMed ID: 20578066
[TBL] [Abstract][Full Text] [Related]
50. Drug resistance mutations and newly recognized treatment-related substitutions in the HIV-1 protease gene: prevalence and associations with drug exposure and real or virtual phenotypic resistance to protease inhibitors in two clinical cohorts of antiretroviral experienced patients.
Torti C; Quiros-Roldan E; Monno L; Patroni A; Saracino A; Angarano G; Tinelli C; Lo Caputo S; Tirelli V; Mazzotta F; Carosi G; ;
J Med Virol; 2004 Sep; 74(1):29-33. PubMed ID: 15258965
[TBL] [Abstract][Full Text] [Related]
51. Prevalence of minor variants of HIV strains at reverse transcriptase position 103 in therapy-naïve patients and their impact on the virological failure.
Balduin M; Oette M; Däumer MP; Hoffmann D; Pfister HJ; Kaiser R
J Clin Virol; 2009 May; 45(1):34-8. PubMed ID: 19375978
[TBL] [Abstract][Full Text] [Related]
52. [Epidemiology of genotypic resistance of HIV-1 in Valencia. A 4-year study].
Molina JM; Córdoba J; Gil A; Gobernado M
Rev Esp Quimioter; 2007 Sep; 20(3):346-53. PubMed ID: 18080033
[TBL] [Abstract][Full Text] [Related]
53. Antiretroviral genotypic resistance in plasma RNA and whole blood DNA in HIV-1 infected patients failing HAART.
Saracino A; Gianotti N; Marangi M; Cibelli DC; Galli A; Punzi G; Monno L; Lazzarin A; Angarano G;
J Med Virol; 2008 Oct; 80(10):1695-706. PubMed ID: 18712823
[TBL] [Abstract][Full Text] [Related]
54. Increasing prevalence of HIV-1 protease inhibitor-associated mutations correlates with long-term non-suppressive protease inhibitor treatment.
Kagan RM; Cheung PK; Huard TK; Lewinski MA
Antiviral Res; 2006 Aug; 71(1):42-52. PubMed ID: 16600392
[TBL] [Abstract][Full Text] [Related]
55. Discordant genotypic interpretation and phenotypic role of protease mutations in HIV-1 subtypes B and G.
Santos AF; Abecasis AB; Vandamme AM; Camacho RJ; Soares MA
J Antimicrob Chemother; 2009 Mar; 63(3):593-9. PubMed ID: 19136678
[TBL] [Abstract][Full Text] [Related]
56. Natural resistance-associated mutations to Enfuvirtide (T20) and polymorphisms in the gp41 region of different HIV-1 genetic forms from T20 naive patients.
Carmona R; Pérez-Alvarez L; Muñoz M; Casado G; Delgado E; Sierra M; Thomson M; Vega Y; Vázquez de Parga E; Contreras G; Medrano L; Nájera R
J Clin Virol; 2005 Mar; 32(3):248-53. PubMed ID: 15722032
[TBL] [Abstract][Full Text] [Related]
57. Use of drug resistance sequence data for the systematic detection of non-B human immunodeficiency virus type 1 (HIV-1) subtypes: how to create a sentinel site for monitoring the genetic diversity of HIV-1 at a country scale.
Yahi N; Fantini J; Tourres C; Tivoli N; Koch N; Tamalet C
J Infect Dis; 2001 May; 183(9):1311-7. PubMed ID: 11294661
[TBL] [Abstract][Full Text] [Related]
58. Polymorphism and drug selected mutations of reverse transcriptase gene in 102 HIV-1 infected patients living in China.
Liu L; Lu HZ; Henry M; Tamalet C
J Med Virol; 2007 Oct; 79(10):1593-9. PubMed ID: 17705165
[TBL] [Abstract][Full Text] [Related]
59. [Prevalence of antiretroviral drug genotypic resistance among HIV patients in Cuenca, Spain].
Rodriguez-Escudero MJ; Prada de Medio E; Rosa Herranz C; Martinez Medina MC; Franquelo Gutierrez R
Rev Esp Quimioter; 2007 Jun; 20(2):203-5. PubMed ID: 17893756
[TBL] [Abstract][Full Text] [Related]
60. [Background study of HIV-1 drug resistant mutations in treatment-naive patients in liaoning province].
Han XX; Zhang M; Dai D; Lu C; Zhang ZN; Liu J; Wang YN; Jiang YJ; Shang H
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Oct; 28(5):632-6. PubMed ID: 17121220
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
